Researchers believe the trick may be to pay workers at least $75 to get screened once.

But the new GLP-1 agonist obesity and diabetes fighters took up more rungs on Milliman's list of top cash eaters.

But a rating agency expects the new weight loss drugs to reduce spending on bariatric surgery.

Viking Therapeutics' dual-action contender could add to pharmacy benefits cost pressure.

Bernie Sanders' committee voted 20-1 to investigate the hospital company and 16-4 for the subpoena.

Rep. Nick Langworthy asked about duty of care at a committee hearing featuring three top PBM executives.

A new report also reveals how much sicker platinum plan enrollees really are.

Employers may be doing better than other payers at holding costs down.